Transcode Therapeutics Inc（RNAZ）價格預測

$2.100

-0.077 (-3.67%)收盤時

價格預測

1-Day Price Prediction

+0.30%

1-Week Prediction

+1.81%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

在 App 中開啟以解鎖更長週期的預測。

Loading chart…

RNAZ 相似圖表分析預測

Alphio's RNAZ stock price prediction model matches the current Transcode Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.11 (+0.30%). The 1-week path is $2.14 (+1.81%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

該買進 Transcode Therapeutics Inc 股票嗎？

Transcode Therapeutics Inc (RNAZ) is not a good buy right now due to its extremely low RSI of 6.667, indicating it is oversold, and a staggering year-to-date change of -70.54%, suggesting a significant decline in value. The forward P/E ratio is 0, indicating no expected earnings, and the stock has a current price of 2.18, which is far below its historical SMA of 7.604. The main risk is the negative net income, which reached -19,510,296 in Q1 2026, reflecting ongoing financial struggles.

RNAZ 股價於 Monday 收在 $2.10，此前下跌 -3.67%

Transcode Therapeutics Inc (RNAZ) last closed at $2.1, losing -3.67%. These facts feed the 1-day and 1-week RNAZ price prediction above.

預測驅動因素

Transcode Therapeutics Inc（RNAZ）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Negative

Bearish

SMA 200

Negative

Bearish

相似圖表形態

近期走勢與 RNAZ 最接近的股票，依相似度排序。

HLF

89.44%

+14.16%

KVUE

89.39%

-1.29%

89.15%

+11.63%

YPF

89.07%

+5.97%

KNX

88.80%

-14.77%

RNAZ 季節性分析

Historically the probability of a positive September return for RNAZ is 0.00%. February offers the highest probability of a positive month at 60.34%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…